Pfizer Merger Hangs Wyeth Investors Out To Dry: Suit

Law360, New York (April 17, 2009, 12:00 AM EDT) -- Wyeth Inc. shareholders have filed an amended complaint in their bid to halt a $68 billion merger between Wyeth and pharmaceutical giant Pfizer Inc., claiming the proposed deal isn't in the best interest of noteholders and demanding that the drugmakers disclose critical information about the merger.

A putative class of Wyeth shareholders filed their amended complaint Thursday in the U.S. District Court for New Jersey against Wyeth, nine members of its board of directors and Pfizer, seeking to enjoin the proposed transaction on grounds that it...
To view the full article, register now.